WASHINGTON, D.C. (February 14, 2003) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement concerning the death of Dolly, the cloned sheep:
“The announcement in February 1997 of the birth of Dolly clearly captured the imagination of the world. While we cannot yet be sure why Dolly died, we can be sure that she opened up significant new areas of medical research and veterinary science that could be of great benefit in the future.”
The Biotechnology Industry Organization (BIO) represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products. For more information on BIO, visit our website at www.bio.org.